ProQR Therapeutics PRQR
NASDAQ PRQR
$2.07 -0.02 (-0.96%)
At close: Sep 4, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Prepaid Assets (2013 - 2025)

ProQR Therapeutics (PRQR) posted Prepaid Assets of $3.7 million for Q1 2026, up 21.67% sequentially from $3.1 million in Q4 2025, and up 21.55% YoY from $3.1 million in Q1 2025.

Analysis

ProQR Therapeutics (PRQR) Prepaid Assets (2013 - 2025) Analysis & Trends

ProQR Therapeutics has reported Prepaid Assets for 14 years, with the latest figure at $3.7 million in Q1 2026.

  • Quarterly Prepaid Assets rose 21.55% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 21.55% YoY) and the FY2025 annual result came in at $3.1 million, up 18.74% from the prior year.
  • Prepaid Assets rose to $3.7 million in Q1 2026 per PRQR's latest filing, from $3.1 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $4.5 million in Q1 2022 and troughed at $853220.3 in Q4 2023.
  • A 5-year average of $2.7 million and a median of $2.5 million in 2022 frame the typical range for Prepaid Assets.
  • The widest YoY moves for Prepaid Assets: up 82950.63% in 2022, down 87.0% in 2022.
  • Over 5 years, Prepaid Assets stood at $2.5 million in 2022, then tumbled by 65.85% to $853220.3 in 2023, then jumped by 201.83% to $2.6 million in 2024, then gained by 18.74% to $3.1 million in 2025, then gained by 21.67% to $3.7 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $3.7 million, $3.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 ProQR Therapeutics 218.57 Mn 82.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.53 Mn
Jun 30, 2025 4.45 Mn
Mar 31, 2025 5.40 Mn
Dec 31, 2024 4.00 Mn
Sep 30, 2024 2.72 Mn
Jun 30, 2024 5.51 Mn
Mar 31, 2024 4.15 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 3.92 Mn
Jun 30, 2023 2.38 Mn
Mar 31, 2023 2.33 Mn
Dec 31, 2022 60.27 Mn
Sep 30, 2022 3.13 Mn
Jun 30, 2022 4.44 Mn
Mar 31, 2022 4.54 Mn
Dec 31, 2021 3.89 Mn
Sep 30, 2021 24.07 Mn
Jun 30, 2021 4.53 Mn
Mar 31, 2021 5.47 Mn
Dec 31, 2020 4.49 Mn